Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer

Published:2017-01 Issue:1 Volume:18 Page:50-59
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wakelee Heather,Zvirbule Zanete,De Braud Filippo,Kingsley C. Daniel,Mekhail Tarek,Lowe Thomas,Schütte Wolfgang,Lena Hervé,Lawler William,Braiteh Fadi,Cosgriff Thomas,Kaen Diego,Boyer Michelle,Hsu Jessie,Phan See,Novello Silvia

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Lung cancer;Herbst;N Engl J Med,2008

2. The evolving role of histology in the management of advanced non–small-cell lung cancer;Langer;J Clin Oncol,2010

3. Met, metastasis, motility and more;Birchmeier;Nat Rev Mol Cell Biol,2003

4. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance;Ichimura;Jpn J Cancer Res,1996

5. Onartuzumab plus erlotinib versus erlotinib in previously treated stage IIIb or IV NSCLC: results from the pivotal phase III randomized, multicenter, placebo-controlled METLung (OAM4971g) global trial;Spigel;J Clin Oncol,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Mesenchymal Epithelial Transition Factor (MET) and Its Impact in the Development and Treatment of Non-Small-Cell Lung Cancer;Cancers;2023-07-27

2. The Role of MET in Resistance to EGFR Inhibition in NSCLC: A Review of Mechanisms and Treatment Implications;Cancers;2023-05-31

3. MET alterations in advanced non-small cell lung cancer;Lung Cancer;2023-04

4. Molecular mechanism of VEGF and its role in pathological angiogenesis;Journal of Cellular Biochemistry;2022-10-26

5. An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer;Frontiers in Molecular Biosciences;2022-06-08